Ring vaccination against foot-and-mouth disease

The study of the available information, notably after the epizootic of foot-and-mouth disease (FMD) which raged in Western Europe in 2001, shows that, in the current conditions of the international sanitary rules relative to this disease, in a FMD-free country of Western Europe accidentally infected, ring vaccination is a solution which, with regard to preventive slaughter, contains more inconveniences (notably economic) than advantages. The appeal to ring vaccination would be interesting only as far as the international sanitary rules would be modified by taking into account the results expected from the coordinated use of highly purified vaccines and differential research kits (vaccine-linked versus infection-linked antibodies). Propositions are this way made.

Résumé

L'étude des informations disponibles, notamment après l'épizootie de fièvre aphteuse qui a sévi en Europe occidentale en 2001, montre que, dans les conditions actuelles de la réglementation sanitaire internationale relative à cette maladie, dans un pays indemne d'Europe occidentale accidentellement infecté, la vaccination périfocale est une solution qui, par rapport à l'abattage préventif, comporte davantage d'inconvénients (notamment économiques) que d'avantages. Le recours à la vaccination périfocale ne serait intéressant que dans la mesure où la réglementation sanitaire internationale serait modifiée en prenant en compte les résultats attendus de l'emploi coordonné de vaccins hautement purifiés et de coffrets de dépistage différentiel (anticorps post infection/anticorps post vaccinaux). Des propositions sont faites en ce sens.     

Aspects of emergency vaccination against foot-and-mouth disease

Emergency vaccination is one of several measures which may be deployed to control outbreaks of foot-and-mouth disease. It can be a valuable adjunct to the application of the essential zoosanitary controls which must include rapid diagnosis, tracing, movement control and disinfection and which may also include slaughter of infected and in-contact animals and their safe disposal. Criteria which determine the successful application of emergency vaccination include access to vaccine(s) that (i) contain virus strain(s) of sufficient antigenic relatedness to the outbreak strain(s) (ii) are of the required type of vaccine formulation (iii) have acceptable innocuity and potency (iv) have appropriate availability, including quantity and immediacy of supply and (v) meet considerations of cost. Contingency planning should include provision for emergency vaccination and must address the complex decisions of not only when, where, and how to apply vaccine but also its economic consequences. Computer modelling may be a useful aid to cost benefit and decision support systems in this context. Planning must be detailed and regularly reviewed and should ensure, (i) that the legal and financial aspects are catered for (ii) that any contractual supply agreements are in place (iii) that information is collected and its currency maintained on the species, numbers and whereabouts of susceptible livestock (iv) that vaccination teams are formed and trained (v) that the vaccine cold chain is established and maintained (vi) that supplies of vaccination equipment are held in readiness and (vii) that briefing materials are available to inform the various stakeholders on relevant aspects of emergency vaccination. Knowledge concerning the characteristics and performance of emergency vaccines is summarised and areas identified for further research.     

Endurance of immunity against foot-and-mouth disease in cattle after three consecutive annual vaccinations

Protection against foot-and-mouth disease (FMD) and ability to transmit FMD virus to susceptible contact animals were studied in cattle vaccinated three times in annual field campaigns with the Dutch trivalent vaccine. Eighty vaccinated cattle and 16 susceptible controls were intranasally exposed to an aerosol containing a homologous FMD challenge virus (O1 BFS, A10 Holland or C1 Detmold) or a heterologous virus (A5 Modena or C1 Modena). The day after exposure, vaccinated cattle were stabled individually with an FMD-susceptible contact. All cattle challenged with an homologous virus strain at one year (20 head), at two years (10 head) and at three years (30 head) after the last vaccination were protected against the development of clinical signs of disease; one, zero and five cattle of these groups, respectively, transmitted virus to their contacts. In each group, approximately two out of three exposed cattle had virus-positive oropharyngeal fluid samples and seroconverted. The amount of virus recovered from probang samples increased with the time since the last vaccination. Mean antibody titres of cattle that had not been vaccinated for three consecutive years did not change significantly over the last two-year period. All 10 cattle challenged with the vaccine strain-related C1 Modena virus were protected against clinical disease, whereas three out of 10 challenged with the heterologous A5 Modena strain virus one year after the last vaccination contracted FMD and transmitted the virus. Five others (four in the C1 group and one in the A5 group) spread the virus to their contacts.(ABSTRACT TRUNCATED AT 250 WORDS)     

4种ELISA检测奶牛O型口蹄疫免疫抗体的比较试验

口蹄疫(FMD)是由口蹄疫病毒引起的以感染偶蹄动物为主的急性、热性、高度传染性疫病,世界动物卫生组织(OIE)将其列为必须报告的动物疫病.我国规定为一类动物疫病.我国奶牛口蹄疫的防控,以免疫接种措施为核心,实行强制免疫政策,要求O型和Asia Ⅰ型疫苗免疫密度必须达100%,通过牛群整体免疫水平的提高来预防口蹄疫的感染和流行[1].     

牛口蹄疫病毒VP2结构蛋白抗体间接ELISA方法的建立

为建立牛口蹄疫(FMD)抗体的检测方法,本研究将口蹄疫病毒(FMDV)的VP2基因,通过pPROEXTM HTb表达载体在大肠杆菌DH5α中表达,获得大小为35ku的重组VP2蛋白(rVP2),western blot证实rVP2可与FMDV5种血清型的牛阳性血清发生特异性反应。以纯化复性的rVP2为抗原建立了FMDVrVP2间接ELISA方法。重复性试验证实批内、批间变异系数均小于10%。特异性交叉试验表明,该抗原不与常见的其他7种牛病阳性血清发生交叉反应。检测非免疫无口蹄疫国家牛阴性血清的特异性为100%;检测感染血清敏感性为97.3%;检测O-AsiaⅠ的二价苗免疫牛血清,与4种商品化试剂盒比较,其符合率分别为69.0%、95.0%、90.4%和86.8%。实验结果表明建立的ELISA方法可以用于口蹄疫感染和免疫抗体检测。     

Presence of antibodies to non-structural proteins of foot-and-mouth disease virus in repeatedly vaccinated cattle

For the purpose of removing infected animals by detecting humoral immune responses to non-structural proteins of the foot-and-mouth disease (FMD) virus, antibodies induced by contaminated residual non-structural proteins contained in less pure FMD vaccine can be problematic for serological screening. The aim of the present study was to measure the possible presence of antibodies against these non-structural proteins in repeatedly vaccinated calves and beef cattle. Five imported FMD vaccines were examined using two commercial ELISA kits, UBI FMDV NS EIA and Ceditest FMDV-NS, for serological testing. After five doses of vaccination, the serum of one calf tested positive, and two vaccines induced a significant increase in anti-3ABC antibodies in calves. This finding demonstrated that a positive reaction to non-structural proteins due to impurities in the FMD vaccine was detectable using commercial tests. A low percentage of field sera sampled from beef cattle in Kinmen also tested positive, but the key factor resulting in the positive reactions could not be positively identified based on our data.     

The development of immunity after vaccination of cattle against trichophytosis

Trials were conducted with 262 one-month-old calves. Good immunity was found to have developed within the period of 21 to 28 days after the administration of the Czechoslovak live vaccine against bovine trichophytosis. After epicutaneous inoculation of a highly virulent culture of Trichophyton verrucosum, performed 28 and 35 days after re-vaccination, no clinical form of trichophytosis was observed to rise in the calves. The same doses of challenge inoculum induced profound trichophytic changes. In the groups of calves artificially infected on the day of re-vaccination and seven days after re-vaccination, the proportions of experimental animals that fell ill were 88.2% and 44.4%, respectively; in the majority of cases, the course of the disease was not so serious as in the controls. Calves challenged 11 to 21 days after the second administration of the vaccines were mostly resistant to experimental infection: slight changes occurred in 15.4 to 7.0% of the tested animals.     

Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines

A single dose of foot-and-mouth disease (FMD) virus protein 1 (VP1) peptide, expressed in Escherichia coli as a fusion protein with 190 amino acids (AA) of the LE' protein of the tryptophan operon of E coli, elicited an immune response in steers sufficient to withstand the challenge of exposure to animals with acute FMD. The 58-micrograms dose of viral peptide, composed of a segment of the VP1 from the A12 strain (A12) of FMD virus (FMDV; A12-32dimer) in a tandem repeat configuration of AA137 through 168 and emulsified with oil adjuvant, elicited a serologic response in cattle equivalent to that obtained using conventional whole virus vaccines. Two groups of swine were vaccinated, 1 with the A12-32dimer as used in cattle and 1 with AA131 through 157 from VP1 of the A24 strain (A24) of FMDV (A24-peptide), expressed in the same system as A12-32dimer, but as a single copy per molecule. In swine, the 58-micrograms dose of the A12-32dimer repeated at 28 days was an effective immunogen; all swine were protected against A12 and, in addition, the vaccine protected 50% of the swine against A24. The 29-micrograms dose of A24-peptide, administered according to the same schedule, elicited protection against A24 in 50% of the vaccinates and, in addition, protected 25% of those vaccinates against A12. The serologic response elicited by A12-32dimer against A24 virus was considerably greater than the response elicited by A24-peptide against A12 virus. The evidence of multiple immunogenic epitopes between AA131 and AA168 was evaluated.     

Situation of serum antibodies against Newcastle disease virus in slaughter-age ostriches after vaccination campaign in Japan

A total of 516 slaughter-age ostrich sera were collected in Japan during 2006-2009. Sixty-one of five hundred and sixteen were positive by virus neutralization (VN) test and the titer of most positive samples was low level. Within the 61 positive sera, 35 sera were collected from unvaccinated ostriches. This result implies that these ostriches might have been infected naturally with low-virulent Newcastle disease virus (NDV). Within the 455 negative samples, 125 samples were from vaccinated ostriches. Since ostrich farmers use live attenuated vaccines, it is reasonable that the titer decreased to below detection level by 1 or 1.5 year-old. The above data indicate that NDV has infiltrated into ostrich farms in Japan, and that the efficacy of ostrich ND vaccination is often time-limited.     

Serological response of cattle to simultaneous vaccinations against foot-and-mouth disease and haemorrhagic septicaemia

In Malaysia, where vaccination campaigns against foot-and-mouth disease and haemorrhagic septicaemia are routinely carried out, it was desirable to determine whether it was safe and efficacious to administer both vaccines simultaneously. A trial group of 104 cattle was divided into three groups; group 1 animals received both vaccines simultaneously, group 2 animals received only foot-and-mouth disease vaccine and group 3 animals received only haemorrhagic septicaemia vaccine. The serological response to vaccinations was monitored at 0, 21 and 35 days by the virus neutralisation test for foot-and-mouth disease and the mouse-protection and indirect haemagglutination tests for haemorrhagic septicaemia. The simultaneous administration of the two inactivated vaccines produced no adverse effects and the serological response did not differ from the response to either vaccine given separately, thus indicating that cattle may be safely and effectively vaccinated simultaneously in this way.     

The carrier state in cattle in foot-and-mouth disease

Abstract

Extract

The possibility of cattle recovering from foot-and-mouth disease and subsequently transmitting it to susceptible animals has been a matter of speculation for some considerable time. This has been particularly so in outbreaks of the disease in which the origin could not be explained in any other way. To cite a few instances, during the winter of 1893–4 in Denmark, foot-and-mouth disease reappeared on four large farms on which outbreaks had taken place from 6 to 12 months previously. In each case, it was observed that only newly purchased calves and cattle introduced since the previous outbreak became affected. The disease was stamped out by killing all the new cattle, but, in spite of this, a third outbreak occurred 12 months after the second outbreak on one of the farms when new cattle were again introduced, affecting only the new animals (Anon., 1901 Anon. Foot-and-mouth disease J. comp. Path. 1901 14 65 68  [Google Scholar]; Bang, 1912 Bang, B. 1912. Foot-and-mouth disease. J. comp. Path., 25: 1–15.  [Google Scholar]). The source of infection could not be determined, particularly as the rest of the country had been free of the disease during the period.     

Comparison of precipitin antibodies and virus-neutralizing antibodies to infectious bursal disease virus

Three hundred twenty-two serum samples from commercial pullets and multiplier breeders were analyzed for agar-gel precipitin (AGP) antibodies and virus-neutralizing (VN) antibodies to infectious bursal disease virus. Two hundred thirty-four of these sera were AGP-positive, and 88 were AGP-negative. The geometric mean of the reciprocal of the VN titers for the AGP-positive sera was 208.7, and 232 (99.1%) had a VN titer of 1:16 or greater. In contrast, the geometric mean of the reciprocal of the VN titers for the AGP-negative sera was 6.1, but 53 (60.2%) had a VN titer ranging from 1:4 to 1:256. When the AGP test was compared with the VN test, the sensitivity and specificity, respectively, of the AGP test were 81.5% and 100%.     

Effect of the sow vaccination regimen on the decay rate of maternally derived foot-and-mouth disease antibodies in piglets

Three pairs of sows were vaccinated against foot-and-mouth disease (FMD) at various intervals before farrowing and samples of blood were collected from their piglets periodically for 70 days after birth. When the sows were vaccinated 12 to 13 days before farrowing the predominating FMD neutralising antibody at time of parturition was IgM and the observed half lives of the maternally derived antibodies in the piglets were short (four to eight days). However, when sows were last vaccinated 30 to 32 days before farrowing, the maternally derived FMD neutralising antibodies in the piglets were predominantly IgG and the observed half lives were seven to 21 days. These observed half lives for IgG were shown to be closely related to the period over which the maternally derived antibodies could be demonstrated and to the rate of increase of the piglet's blood volume over the same period. If corrections were made for increase in blood volume the decay rate of IgM antibodies in piglets was seven to 18 days while the decay rate for IgG was greater than 408 days. This result suggested that there was little or no IgG catabolism or excretion during the first 70 days of the piglet's life.     

Foot-and-mouth disease. Infection trial in cattle after a single vaccination

Following an outbreak of FMD caused by an A5 strain in the spring of 1984, ten cattle were vaccinated with samples of the five commercial vaccines used for the vaccination campaign in that year, i.e. two animals per vaccine. Six weeks later the cattle were challenged by contact with animals inoculated with the virus strain isolated from the field outbreak. Seven of the ten cattle became severely ill, exhibiting the typical symptoms of FMD, one animal did not show any clinical symptoms, the remaining two weak ones that might have escaped recognition by the cattlemen. Virus could be recovered from the vaccinated animals from days 2 to 10 following contact with the non-vaccinated infected cattle. It was concluded that a single vaccination does not protect cattle against the isolate.